Our in vivo results confirmed that 3 ng of GluOC increases the serum osteocalcin concentration in mice, promotes the lung metastasis of breast cancer, and induces inflammatory responses, which are important drivers of TNBC aggressiveness. This evidence concerns the gene BGLAP and breast carcinoma.